Literature DB >> 12742158

Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis. a summary of 154 cases.

Yao-Shan Fan1, Kamilia Rizkalla.   

Abstract

Cytogenetic analysis including multicolor spectral karyotyping (SKY) and interphase fluorescence in situ hybridization (FISH) was performed on 154 consecutive cases with suspected lymphoma. The cytogenetic results were reviewed in correlation with the final pathologic diagnosis. A diagnosis of lymphoma was established in 94 cases, with 16 Hodgkin lymphomas and 78 non-Hodgkin lymphomas (NHL). Cytogenetic results were obtained in 63 NHLs (81%); 61 of those showed abnormal karyotypes (97%). The t(14;18) or IGH-BCL2 fusion was detected in 83% (20/24) of follicular lymphomas and in 57% (12/21) of diffuse large B-cell lymphomas (DLBCL). The application of interphase FISH and SKY has contributed to a high detection rate of t(14;18) in DLBCLs. This study showed that genes at 1q25, 3p21, 3q21, 5q31, 6p23, 7q22, 8q11 approximately q12, 9q34, 11q23, 12q13, and 19q13.1 may have been involved as the less common changes in follicular lymphoma and DLBCL. Comparison of the recurrent secondary aberrations in the groups of follicular lymphoma and DLBCL revealed a pattern of clonal evolution from the changes rea(1)(p36), del(6q), +7, +12 or dup or trp(12)(q13q22), +der(18)t(14;18), and +21 in follicular lymphoma to the changes rea(1)(p36), del(6q), +6, +7, +9, rea(11)(q23), +12, -13 or del(13(q12q14), +18, +21, and +X in DLBCL. The clonal evolution of the secondary aberrations is thought to contribute to the progression of the disease. About 90% (16/18) of other types of NHL had abnormal karyotypes showing specific translocations or gene rearrangements consistent with the pathologic diagnosis. A comprehensive cytogenetics approach including SKY and interphase FISH using probes for specific genes, such as IGH, BCL2, CCND1, and ALK, is a very useful ancillary diagnostic tool for lymphomas. The combined approach also led to the identification of t(2;19)(p23;q13.1) as a new variant of t(2;5)(p23;q35) in a case of Ki-1-positive anaplastic large cell lymphoma with a null cell phenotype.

Entities:  

Mesh:

Year:  2003        PMID: 12742158     DOI: 10.1016/s0165-4608(02)00843-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Authors:  Colleen L Doçi; Tanmayi P Mankame; Alexander Langerman; Kelly R Ostler; Rajani Kanteti; Timothy Best; Kenan Onel; Lucy A Godley; Ravi Salgia; Mark W Lingen
Journal:  Int J Gynecol Pathol       Date:  2012-01       Impact factor: 2.762

2.  Identification and characterization of the human NOL7 gene promoter.

Authors:  Tanmayi P Mankame; Guolin Zhou; Mark W Lingen
Journal:  Gene       Date:  2010-03-03       Impact factor: 3.688

3.  Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Authors:  Taku Tsukamoto; Miki Kiyota; Eri Kawata; Nobuhiko Uoshima; Shotaro Tatekawa; Yoshiaki Chinen; Hisao Nagoshi; Shinsuke Mizutani; Yuji Shimura; Mio Yamamoto-Sugitani; Tsutomu Kobayashi; Shigeo Horiike; Satoru Yasukawa; Akio Yanagisawa; Masafumi Taniwaki; Junya Kuroda
Journal:  Int J Hematol       Date:  2016-12-19       Impact factor: 2.490

4.  A case of EBV positive diffuse large B-cell lymphoma of the adolescent.

Authors:  Qilin Ao; Ying Wang; Sanpeng Xu; Ye Tian; Wei Huang
Journal:  Int J Clin Exp Med       Date:  2014-01-15

5.  Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.

Authors:  Deirdre A Hill; Sophia S Wang; James R Cerhan; Scott Davis; Wendy Cozen; Richard K Severson; Patricia Hartge; Sholom Wacholder; Meredith Yeager; Stephen J Chanock; Nathaniel Rothman
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

6.  Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells.

Authors:  Er-Qun Song; Jun Hu; Cong-Ying Wen; Zhi-Quan Tian; Xu Yu; Zhi-Ling Zhang; Yun-Bo Shi; Dai-Wen Pang
Journal:  ACS Nano       Date:  2011-01-20       Impact factor: 15.881

Review 7.  Best Practice No 185. Cytological and molecular diagnosis of lymphoma.

Authors:  G Kocjan
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

8.  Identification and functional analysis of NOL7 nuclear and nucleolar localization signals.

Authors:  Guolin Zhou; Colleen L Doçi; Mark W Lingen
Journal:  BMC Cell Biol       Date:  2010-09-27       Impact factor: 4.241

9.  Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.

Authors:  Cindy M Chang; Jane C Schroeder; Wen-Yi Huang; Cherie H Dunphy; Ralph S Baric; Andrew F Olshan; Kathleen C Dorsey; Georgette A Dent; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair
Journal:  Leuk Res       Date:  2009-06-07       Impact factor: 3.156

10.  Clinical Significance of ALK-1 Gene Abnormalities in Diffuse Large Cell Lymphoma.

Authors:  L Korashy; H El-Zawahry; S Abdou; D Shahin; F Sherif; W Farrag; O Abdel-Khalik; H Salem; A El-Sebaaie
Journal:  Clin Med Insights Oncol       Date:  2012-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.